LogiPharma Europe

Supply chain data across stationary and in-transit monitoring can accelerate product release and reduce waste for pharma companies.

Ben Sharples, LogiPharma event director, examines how life sciences organizations are adapting to AI in the supply chain, with expert testimony from LogiPharma partners.

Clemens Twardy says pharma supply chains must align with commercial goals through transparency, trust, and AI-driven speed.

Nico Vandaele shares how advanced modeling and simulations can be used to get ahead of future supply chain disruptions.

Raquel Vazquez discusses how data can be incorporated to make key decisions within the cold chain.

Joydeep Ganguly evaluates 4IR tools, data strategy, and why end-to-end thinking will define pharma supply chain transformation.

Anthony "TJ" Rizzo explains how modern tools are enabling more oversight and precision within the cold chain.

Ahead of LogiPharma Europe 2026, Richard Harrop explains why packaging must be more patient-centric.

Anthony “TJ” Rizzo shares his outlook on the future of pharma cold chain technology.

Anthony “TJ” Rizzo explains what makes an effective supply chain partnership, and how tech can be deployed alongside human experience.

Richard Harrop shares how pharma can strike a balance between performance, sustainability, and resilience in packaging design.

Seamus Keane discusses resilient supply chain design ahead of his panel at LogiPharma 2026.

Ahead of his presentation at LogiPharma 2026, Anthony “TJ” Rizzo discusses how automation and real-time monitoring can be deployed in supply chains.

LogiPharma 2026 in Vienna debuts interactive, hands-on formats and a two-track structure to boost collaboration, training, and real-time engagement for life sciences supply chains.

Ruth Beadle, head, global supply chain, Sanofi, discusses how digital integration, advanced planning, and sustainability goals are transforming end-to-end supply chain operations to improve scale, speed, and environmental impact.

Ruth Beadle, head, global supply chain, Sanofi, discusses the company’s multi-year effort to build an AI-powered, end-to-end supply chain focused on improving service, resilience, and cost efficiency.

Ruth Beadle, head, global supply chain, Sanofi, explains how the company balances daily operations with long-term transformation efforts to ensure timely delivery of critical medications to patients.

Joydeep Ganguly, SVP, corporate operations, interim CIO, Gilead Sciences, shares how stakeholders can drive meaningful, lasting impact by turning pledges into proof points, exercising patience, and embedding sustainability into core business operations.

Joydeep Ganguly, SVP, corporate operations, interim CIO, Gilead Sciences, shares insights on how sustainability has evolved from a compliance requirement to a key business strategy, driving operational efficiencies, innovation, and long-term growth.

Will Robinson, program director, LogiPharma, shares how in-depth conversations—not AI—drive the research behind one of the industry's most anticipated annual agendas.

Will Robinson, program director, LogiPharma, explains how artificial intelligence and sustainability are driving a clear shift in priorities across the pharmaceutical supply chain.

Will Robinson, program director, LogiPharma, reveals why the conference will be moved to Vienna moving forward.

A panel discussion uncovers ways to deliver personalized therapy ops in a timely fashion.

Steffen Lang, president, operations, executive committee member, Novartis, discusses what to expect from Novartis over the next decade in terms of technological innovations.

Steffen Lang, president, operations, executive committee member, Novartis, discusses how technology will continue to enhance operations and how it will impact patients.

Steffen Lang, president, operations, executive committee member, Novartis, shares strategic insights on how pharma supply chain leaders can elevate operations to drive innovation, growth, and patient impact.

How can stakeholders prepare for changing therapy requirements?

A keynote presentation describes how supply chain visibility should rely on digital capabilities.

Steffen Lang, president, operations, executive committee member, Novartis, discusses the premise of a keynote session on reimagining operations.